Search Query :
6WTK
Feline coronavirus drug inhibits the main protease of sars-cov-2 and blocks virus replication Deposition Author(s): Arutyunova, E. , Khan, M.B. , Lemieux, M.J. , Young, H.S.
Date: 2020-05-03 Method: X-RAY DIFFRACTION Resolution: 2 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 6WTK_A
6WTM
Feline coronavirus drug inhibits the main protease of sars-cov-2 and blocks virus replication Deposition Author(s): Arutyunova, E. , Khan, M.B. , Lemieux, M.J. , Young, H.S.
Date: 2020-05-03 Method: X-RAY DIFFRACTION Resolution: 1.85 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 6WTM_A , 6WTM_B
7DMX
Photocleavable fluorescent protein in green form Deposition Author(s): Lemieux, M.J. , Wen, Y.
Date: 2020-12-08 Method: X-RAY DIFFRACTION Resolution: 2.1 Å Organism(s): Aequorea Victoria Sequences Data: 7DMX_A , 7DMX_B , 7DMX_C , 7DMX_D
7E9Y
Crystal structure of elacco1 Deposition Author(s): Campbell, R.E. , Lemieux, M.J. , Nasu, Y. , Wen, Y.
Date: 2021-03-05 Method: X-RAY DIFFRACTION Resolution: 2.25 Å Organism(s): Thermus Thermophilus , Thermus Thermophilus Hb8 Sequences Data: 7E9Y_A
7LCO
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability Deposition Author(s): Arutyunova, E. , Khan, M.B. , Lemieux, M.J. , Lu, J. , Young, H.S.
Date: 2021-01-11 Method: X-RAY DIFFRACTION Resolution: 1.9 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 7LCO_A
7LCP
N-terminal finger stabilizes feline drug gc376 in coronavirus 3cl protease Deposition Author(s): Arutyunova, E. , Khan, M.B. , Lemieux, M.J. , Young, H.S.
Date: 2021-01-11 Method: X-RAY DIFFRACTION Resolution: 1.9 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus Sequences Data: 7LCP_A
7LCQ
N-terminal finger stabilizes feline drug gc376 in coronavirus 3cl protease Deposition Author(s): Arutyunova, E. , Khan, M.B. , Lemieux, M.J. , Young, H.S.
Date: 2021-01-11 Method: X-RAY DIFFRACTION Resolution: 2.15 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus Sequences Data: 7LCQ_A
7LCR
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability Deposition Author(s): Arutyunova, E. , Khan, M.B. , Lemieux, M.J. , Young, H.S.
Date: 2021-01-11 Method: X-RAY DIFFRACTION Resolution: 1.95 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 7LCR_A , 7LCR_B
7LCS
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability Deposition Author(s): Arutyunova, E. , Khan, M.B. , Lemieux, M.J. , Young, H.S.
Date: 2021-01-11 Method: X-RAY DIFFRACTION Resolution: 1.85 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 7LCS_A
7LCT
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability Deposition Author(s): Arutyunova, E. , Khan, M.B. , Lemieux, M.J. , Young, H.S.
Date: 2021-01-11 Method: X-RAY DIFFRACTION Resolution: 1.93 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 7LCT_A